Table 1.

Patient Data and Results of First Marrow Grafts

Years of Transplant Group Denomination 1970-1976 Group 1 1977-1981 Group 2 1982-1996 Group 3
No. of patients studied  81  104  148  
Median age in years (range) 17.3 (1.9-60.3)  19.7 (3.0-53.4) 23.6 (1.8-59.0)  
Median (range) months from diagnosis to transplant  2.3 (0.8-108.3) 1.3 (0.33-75)  1.8 (0.5-228.3) 
Preceding transfusions (%) 74 (91)  72 (69)  116 (78) 
Preparative regimen (no. of patients)  
 CY 200 mg/kg 62  104  96  
 CY 200 mg/kg + procarbazine + ATG 36 mg/kg 19  0  0  
 CY 200 mg/kg + ATG 90 mg/kg  0  52  
GVHD prophylaxis  
 Methotrexate  81  86 29  
 Cyclosporine  0  13  3  
 Methotrexate + cyclosporine  0  5  116  
Median marrow cell dose ×108/kg (range)  3.5 (1.0-14.0) 3.2 (1.2-15.5)  2.9 (0.4-11.3)  
Buffy coat infusion (no. of patients)  6  72  47  
No. of patients (%)  
 Rejecting  28 (35) 12 (12)  13 (9)  
 Surviving 34 (42)  64 (61)  108 (74) 
Median days from transplant to rejection (range)  28 (14-984)  47 (14-215) 180 (22-583) 
Years of Transplant Group Denomination 1970-1976 Group 1 1977-1981 Group 2 1982-1996 Group 3
No. of patients studied  81  104  148  
Median age in years (range) 17.3 (1.9-60.3)  19.7 (3.0-53.4) 23.6 (1.8-59.0)  
Median (range) months from diagnosis to transplant  2.3 (0.8-108.3) 1.3 (0.33-75)  1.8 (0.5-228.3) 
Preceding transfusions (%) 74 (91)  72 (69)  116 (78) 
Preparative regimen (no. of patients)  
 CY 200 mg/kg 62  104  96  
 CY 200 mg/kg + procarbazine + ATG 36 mg/kg 19  0  0  
 CY 200 mg/kg + ATG 90 mg/kg  0  52  
GVHD prophylaxis  
 Methotrexate  81  86 29  
 Cyclosporine  0  13  3  
 Methotrexate + cyclosporine  0  5  116  
Median marrow cell dose ×108/kg (range)  3.5 (1.0-14.0) 3.2 (1.2-15.5)  2.9 (0.4-11.3)  
Buffy coat infusion (no. of patients)  6  72  47  
No. of patients (%)  
 Rejecting  28 (35) 12 (12)  13 (9)  
 Surviving 34 (42)  64 (61)  108 (74) 
Median days from transplant to rejection (range)  28 (14-984)  47 (14-215) 180 (22-583) 
Close Modal

or Create an Account

Close Modal
Close Modal